Comprehensive genomic analysis identified more frequent mutations of ACVR2A in non-viral HCC than in viral HCC (Figure 1A), consistent with the previous finding that the ACVR2A mutation rate is higher in NASH-HCC than in other HCC etiologies.15 This evidence concerns the gene ACVR2A and metabolic dysfunction-associated steatohepatitis.